Cargando…
Apatinib for Treatment of Inoperable Metastatic or Locally Advanced Chondrosarcoma: What We Can Learn About the Biological Behavior of Chondrosarcoma from a Two-Center Study
PURPOSE: For patients who have chondrosarcoma in the unresectable setting, antiangiogenic agents are reportedly effective. This multicenter, retrospective study investigated the antitumor activity of apatinib in patients with unresectable chondrosarcoma to gain insight into the biological behavior o...
Autores principales: | Xie, Lu, Xu, Jie, Sun, Xin, Liu, Kuisheng, Li, Xiaowei, He, Fangzhou, Liu, Xinyu, Gu, Jin, Lv, Zhe, Yang, Rongli, Tang, Xiaodong, Yan, Taiqiang, Li, Dasen, Yang, Yi, Dong, Sen, Sun, Kunkun, Shen, Danhua, Guo, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237692/ https://www.ncbi.nlm.nih.gov/pubmed/32547189 http://dx.doi.org/10.2147/CMAR.S253201 |
Ejemplares similares
-
Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial
por: Xie, Lu, et al.
Publicado: (2020) -
Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth
por: Bao, Xing, et al.
Publicado: (2017) -
Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma
por: Zang, Jie, et al.
Publicado: (2020) -
Constitutive GLI1 expression in chondrosarcoma is regulated by major vault protein via mTOR/S6K1 signaling cascade
por: Wang, Wei, et al.
Publicado: (2021) -
Imaging of chondrosarcomas
por: Ollivier, L, et al.
Publicado: (2003)